関連する実験動画
Updated: Sep 9, 2025

05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
838
急性腎臓損傷を段階的に標的とし,慢性腎臓疾患への進行を防止するヒアルロン酸ベースのポリマー前薬
Li-Bin Zhou1, Xuan-Ze Peng1,2, Hui-Min Long1
1Department of Urology, The Affiliated LiHuiLi Hospital of Ningbo University, Ningbo, 315040, China.
Materials today. Bio
|September 2, 2025
まとめ
この研究では,急性腎臓損傷 (AKI) のミトコンドリアを標的としたTPP-HA-TK-MLT (THTM) が開発されました. THTMは腎臓の損傷を効果的に軽減し,慢性腎臓病への進行を防ぎました.
科学分野:
- 生物化学
- 薬理学について
- 腎臓科
背景:
- 急性腎損傷 (Acute Kidney Injury,AKI) は,腎機能の突然の喪失であり,しばしば不血症再注血または毒素によって引き起こされる.
- ミトコンドリア機能障害はAKIの重要な要因であり,エネルギー不足,酸化ストレス,炎症につながる.
- AKI治療に ミトコンドリアをターゲットにするのは 難しいことです
研究 の 目的:
- AKIにおけるミトコンドリア標的の強化のための新しいメラトニン (MLT) デリバティブを開発する.
- TPP-HA-TK-MLT (THTM) を作成し,腎臓細胞におけるMLTの投与と有効性を改善する.
- AKIに対するTHTMの保護効果と慢性腎臓病の進行を防ぐ可能性を評価する.
主な方法:
- TPP-HA-TK-MLT (THTM) の合成は,MLTとトリフェニルフォスフォニウムヒアルロン酸 (TPP-HA) を分割可能なリンカーで結合する.
- CD44受容体による腎管状上皮細胞におけるTHTMの標的化効率とTPPによるミトコンドリア吸収の評価.
- ミトコンドリアの反応性酸素種 (ROS) を抑制し,ミトコンドリアの損傷を軽減し,AKIモデルでのアポトーシスの減少 (イシュミア-再注射,腎毒薬) のTHTMの有効性の評価.
- 葉酸による腎臓損傷が慢性腎臓疾患に進行するのを防ぐためのTHTMの効果の調査.
主要な成果:
- THTMは,腎管状上皮細胞に対するMLT標的の改善と,ミトコンドリアの蓄積の強化を示した.
- THTMはミトコンドリアのROSを効果的に抑制し,ミトコンドリアの透過性と腫れを正常化し,傷害に対する細胞抵抗性を高めました.
- THTMはAKIモデルでアポトーシスを有意に減少させた.
- THTM治療は慢性腎臓病への腎臓損傷の進行を著しく減少させた.
結論:
- THTMは,AKIに対する有望なミトコンドリア標的治療剤です.
- THTMはミトコンドリア機能障害に対処することでAKIを効果的に軽減します.
- THTMは急性腎疾患から慢性腎疾患への移行を防ぐ可能性を示しています.
関連する概念動画
Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Acute Kidney Injury V: Interprofessional Care
44
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
44
Acute Kidney Injury II: Pathophysiology
72
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
72
Acute Kidney Injury I: Introduction
72
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
72
Chronic Kidney Disease III: Interprofessional Care
77
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
77
Acute Kidney Injury III: Clinical Manifestations
90
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
90

